Jabra Enhance Select 50R vs RxEars Rxi

The Jabra Enhance Select 50R is a premium-priced OTC hearing aid at $1,195, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This behind-the-ear device ranks #29 of 65 OTC hearing aids tested, placing it in the top 43% of its category. In our testing, the Select 50R demonstrates notable strengths in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.75 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during typical wear. Music streaming also performs above average at 2.8/5, though this remains mixed in absolute terms. The device shows limitations in challenging listening situations. Speech in noise scores just 1.0/5, falling 0.48 points below the category average—a meaningful weakness for those who frequently encounter noisy environments. Own-voice comfort is mixed at 2.5/5, essentially matching the category average. At this price point, shoppers should note that several competitors deliver stronger overall performance. The Jabra Enhance Select 500 scores 4.16/5, while the Lucid Tala and Audicus Omni 2 both exceed 4.5/5. For those prioritizing value, devices like the Sony CRE-C20 offer similar sound performance at lower prices. The Select 50R is best suited for users who primarily need help hearing in quieter settings and value Jabra's ecosystem and reliable feedback control.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.